Xencor to Present at Upcoming Investor Conferences

Author's Avatar
Nov 10, 2022

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences: